METRONIDAZOLE

Metronidazole

Composition: 1 ml of the solution contains:

active substance: metronidazole – 5 mg.

Therapeutic indications

Protozoal infections: extraintestinal amebiasis, amebic liver abscess included, intestinal amebiasis (amebic dysentery), trichomoniasis, balantidiasis, lambliasis (giardiasis), dermal leishmaniasis, trichomonal vaginitis and trichomonal urethritis.

Infections caused by Bacteroides spp. (including Bacteroides fragilis, Bacteroides distasonis, Bacteroides ovatus, Bacteroides thetaiotaomicro and Bacteroides vulgatus): bone and joint infections, central nervous system infections, including meningitis, cerebral abscess, bacterial endocarditis, pneumonia, pulmonary empyema and abscess and sepsis.

Infections caused by species Clostridium spp., Peptococcus and Peptostreptococcus: abdominal cavity infections (peritonitis and hepatic abscess) and pelvis minor organ infections (endometritis, Fallopian tube and ovary abscess and vaginal vault infections).

Pseudomembranous colitis (antibiotics administration related). Gastritis or duodenal ulcer related to Helicobacter pylori.

Post-surgery complication prevention (particularly operative interventions in colon and pararectal area, appendectomy and gynecological surgeries).

Radiotherapy of tumor patients – as a radiation sensitizing medicinal agent in cases the tumor resistance is due to the tumor cell hypoxia.

	АТС code
	J01XD01
	Pharmaceutical form
	solution for infusion 5 mg/ml
	Storage conditions
	Store in protected from light place at temperature between 15°C and 25°C. Do not freeze.